Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06211296 · ClinicalTrials.gov registry record · NA
The ShortCut™ Continued Access Study Protocol
A NA study of Aortic Stenosis and Valve-in-valve Procedures, sponsored by Pi-cardia.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
- 4
- Study locations
NCT06211296 is a NA study of Aortic Stenosis and Valve-in-valve Procedures that has completed, run by Pi-cardia. The registered enrollment target is 8 participants, below the 1,362-participant average among 26 other Aortic Stenosis trials with a reported enrollment target (99% lower). The trial reports 4 study locations across 4 states.
The verdict
NCT06211296, a NA study of Aortic Stenosis and Valve-in-valve Procedures, has completed, sponsored by Pi-cardia.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
- 4
- Study locations
Study Summary
A Prospective, Multicenter, Non-Randomized, Single-Arm, Open-Label Continued Access Study of the ShortCut™ device (The ShortCut™ CAS).
Conditions Studied
Interventions
- DEVICE Shortcut
Study Locations (4)
California
- Los Robles Regional Medical Center - Thousand Oaks
New Jersey
- Morristown Medical Center - Morristown
New York
- Columbia University Medical Center /NYPH - New York
Pennsylvania
- UPMC Pinnacle - Wormleysburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2024-07-03 |
| Est. Completion | 2025-05-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06211296
The ClinicalTrials.gov registry entry for NCT06211296 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,362-participant average among 26 other Aortic Stenosis trials with a reported enrollment target (99% lower). The listed sponsor is Pi-cardia, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Aortic Stenosis appearing as the primary indexed condition, and to 1 intervention - of which Shortcut is the first listed.
NCT06211296 reports 4 study locations spanning 4 distinct geographic areas - top geographies include California, New Jersey, New York.
Frequently Asked Questions
What is clinical trial NCT06211296 about?
NCT06211296 is a clinical study titled "The ShortCut™ Continued Access Study Protocol". A Prospective, Multicenter, Non-Randomized, Single-Arm, Open-Label Continued Access Study of the ShortCut™ device (The ShortCut™ CAS).
What is the current status of trial NCT06211296?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2024-07-03. Estimated completion is 2025-05-12.
What conditions does trial NCT06211296 study?
This clinical trial studies the following conditions: Aortic Stenosis, Valve-in-valve Procedures, Coronary; Obstruction.
What interventions are being tested in trial NCT06211296?
The interventions under investigation include: Shortcut (DEVICE).
Who is sponsoring clinical trial NCT06211296?
This trial is sponsored by Pi-cardia, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06211296 being conducted?
This trial has 4 study locations across California, New Jersey, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aortic Stenosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Correlation Between an Impedance Cardiography Test for Decompensation and the Development of Left Ventricular Replacement Fibrosis
RECRUITING · NA
-
Evaluating Infrasonic Hemodynography
RECRUITING · NA
-
Improved Outcomes With Pre-Procedure Shockwave IVL of Common Femoral Artery Access Site Prior to Large Bore Access and Pre-Closure
RECRUITING · NA
-
PARTNER 3 Trial - Aortic Valve-in-Valve
RECRUITING · NA
-
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
RECRUITING · NA
-
ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Bioprostheses With a New Tissue Treatment Platform (COMMENCE)
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.